System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Coralie Cantarel is an expert in Oncology at Institut Bergonié (France). Coralie Cantarel has authored 36 publications, the most recent in 2025. SLR score: 134 (community average: 125). How the SLR is computed.

LeadR Profile

Coralie Cantarel Institut Bergonié France
134 ScienceLeadR Reputation 134

Unlock

Register Login
Network Map

Oncology

Subspecialties: Public Health - Biochemistry - Geriatrics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2019 - 2025
Source: PubMed

Institut Bergonié

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 36

Citations

Citations: 470 1st author: 3 Last author: 0 Unique author: 0

Main journals

J Clin Oncol 8
Ann Oncol 4
Cancer Res 3
J Geriatr Oncol 3
Rev Epidemiol Sante Publique 3

Best Journals

J Clin Oncol 8
Ann Oncol 4
Mol Cancer 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Important aspects of care and priorities of older patients with cancer: The PRIORITY multicenter cohort study.
PMID 41233219 — treatment outcome, neoplasms, cohort studies, life expectancy, physicians, therapeutics		J Geriatr Oncol20250
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab.
PMID 40579407 — cells, cold temperature, neoplasms, sarcoma, signal transduction, therapeutics, tissues, tumor microenvironment		Signal Transduct Target Ther Top journal20250
Regorafenib plus avelumab in advanced gastroenteropancreatic neuroendocrine neoplasms: a phase 2 trial and correlative analysis.
PMID 40204996 — neoplasms, biomarkers, therapeutics		Nat Cancer20250
Positive predictive value of malignancy for additional calcifications found during evaluation of a synchronous breast cancer.
PMID 39447424 — breast neoplasms, neoplasms, predictive value of tests, biopsy, radiology, breast, work, multivariate analysis		Eur J Radiol20240
Identification of microenvironment features associated with primary resistance to anti-PD-1/PD-L1 + antiangiogenesis in gastric cancer through spatial transcriptomics and plasma proteomics.
PMID 39272096 — macrophages, neoplasms, biomarkers, proteomics, therapeutics, tumor microenvironment, stomach neoplasms, plasma, spatial transcriptomics		Mol Cancer Top journal202417

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS